1)WHO Classification of Tumours Editorial Board(eds). WHO Classification of Tumours, Digestive System Tumours, 5th ed. IARC press, Lyon, 2019
2)Pai RK, Bettington M, Srivastava A, et al. An update on the morphology and molecular pathology of serrated colorectal polyps and associated carcinomas. Mod Pathol 32:1390-1415, 2019
3)Sugai T, Eizuka M, Fujita Y, et al. Molecular profiling based on KRAS/BRAF mutation, methylation, and microsatellite statuses in serrated lesions. Dig Dis Sci 63:2626-2638, 2018
4)Tanaka Y, Eizuka M, Uesugi N, et al. Traditional serrated adenoma has two distinct genetic pathways for molecular tumorigenesis with potential neoplastic progression. J Gastroenterol 55:846-857, 2020
5)Saito S, Tajiri H, Ikegami M. Serrated polyps of the colon and rectum:endoscopic features including image enhanced endoscopy. World J Gastrointest Endosc 7:860-871, 2015
6)Zhang XT, Zhang QW, Liu F, et al. Endoscopic features of sessile serrated adenoma/polyps under narrowband imaging:A retrospective study. J Dig Dis 20:135-142, 2019
7)Kimura T, Yamamoto E, Yamano HO, et al. A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma. Am J Gastroenterol 107:460-469, 2012
8)Kawasaki K, Kurahara K, Yanai S, et al. Colonoscopic features and malignant potential of sessile serrated adenomas:comparison with other serrated lesions and conventional adenomas. Colorectal Dis 18:795-802, 2016
9)川崎啓祐,永塚真,梁井俊一,他.分子生物学的解析のできた症例—SSA/P由来MSS型大腸癌の1例.Intestine 22:477-484, 2018
10)Eizuka M, Kawasaki K, Toya Y, et al. Colorectal adenocarcinoma with an alternative serrated pathway. Case Rep Gastroenterol 12:116-124, 2018
11)Nishizawa T, Yoshida S, Toyoshima A, et al. Endoscopic diagnosis for colorectal sessile serrated lesions. World J Gastroenterol 27:1321-1329, 2021
12)Kashida H. Endoscopic diagnosis of sessile serrated polyp:A systematic review. Dig Endosc 31:16-23, 2019
13)Murakami T, Kurosawa T, Fukushima H, et al. Sessile serrated lesions:Clinicopathological characteristics, endoscopic diagnosis, and management. Dig Endosc 34:1096-1109, 2022
14)Kawasaki K, Kurahara K, Oshiro Y, et al. Clinicopathologic features of inverted serrated lesions of the large bowel. Digestion 93:280-287, 2016
15)Murakami T, Sakamoto N, Nagahara A. Clinicopathological features, diagnosis, and treatment of sessile serrated adenoma/polyp with dysplasia/carcinoma. J Gastroenterol Hepatol 34:1685-1695, 2019
16)Murakami T, Sakamoto N, Ritsuno H, et al. Distinct endoscopic characteristics of sessile serrated adenoma/polyp with and without dysplasia/carcinoma. Gastrointest Endosc 85:590-600, 2017
17)Nagata S, Mitsuyama K, Kawano H, et al. Endoscopic analysis of colorectal serrated lesions with cancer. Oncol Lett 15:8655-8662, 2018
18)Kim KH, Kim KO, Jung Y, et al. Clinical and endoscopic characteristics of sessile serrated adenomas/polyps with dysplasia/adenocarcinoma in a Korean population:A Korean Association for the Study of Intestinal Diseases(KASID)multicenter study. Sci Rep 9:3946, 2019
19)Chino A, Osumi H, Kishihara T, et al. Advantages of magnifying narrow-band imaging for diagnosing colorectal cancer coexisting with sessile serrated adenoma/polyp. Dig Endosc 28:53-59, 2016
20)Murakami T, Sakamoto N, Fukushima H, et al. Usefulness of the Japan narrow-band imaging expert team classification system for the diagnosis of sessile serrated lesion with dysplasia/carcinoma. Surg Endosc 35:4528-4538, 2021
21)Burgess NG, Pellise M, Nanda KS, et al. Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps. Gut 65:437-446, 2016